These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37599279)

  • 1. Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.
    Cavarra M; Mason NL; Kuypers KPC; Bonnelle V; Smith WJ; Feilding A; Kryskow P; Ramaekers JG
    Eur J Pain; 2024 Jan; 28(1):153-165. PubMed ID: 37599279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.
    Glynos NG; Pierce J; Davis AK; McAfee J; Boehnke KF
    J Psychoactive Drugs; 2023; 55(1):73-84. PubMed ID: 35001856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.
    Bonnelle V; Smith WJ; Mason NL; Cavarra M; Kryskow P; Kuypers KP; Ramaekers JG; Feilding A
    Br J Pain; 2022 Dec; 16(6):619-631. PubMed ID: 36452124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are psychedelics the answer to chronic pain: A review of current literature.
    Kooijman NI; Willegers T; Reuser A; Mulleners WM; Kramers C; Vissers KCP; van der Wal SEI
    Pain Pract; 2023 Apr; 23(4):447-458. PubMed ID: 36597700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.
    Dworkin RH; Anderson BT; Andrews N; Edwards RR; Grob CS; Ross S; Satterthwaite TD; Strain EC
    J Pain; 2022 Oct; 23(10):1666-1679. PubMed ID: 35643270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beating pain with psychedelics: Matter over mind?
    Elman I; Pustilnik A; Borsook D
    Neurosci Biobehav Rev; 2022 Mar; 134():104482. PubMed ID: 34922987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdosing psilocybin for chronic pain: a case series.
    Lyes M; Yang KH; Castellanos J; Furnish T
    Pain; 2023 Apr; 164(4):698-702. PubMed ID: 36066961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelics as preventive treatment in headache and chronic pain disorders.
    Schindler EAD
    Neuropharmacology; 2022 Sep; 215():109166. PubMed ID: 35718005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelics in the Treatment of Headache and Chronic Pain Disorders.
    Schindler EAD
    Curr Top Behav Neurosci; 2022; 56():261-285. PubMed ID: 35546382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential of Psychedelics for the Treatment of Episodic Migraine.
    Schindler EAD
    Curr Pain Headache Rep; 2023 Sep; 27(9):489-495. PubMed ID: 37540398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic pain and psychedelics: a review and proposed mechanism of action.
    Castellanos JP; Woolley C; Bruno KA; Zeidan F; Halberstadt A; Furnish T
    Reg Anesth Pain Med; 2020 Jul; 45(7):486-494. PubMed ID: 32371500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapting psychedelic medicine for headache and chronic pain disorders.
    Schindler EAD; Hendricks PS
    Expert Rev Neurother; 2023; 23(10):867-882. PubMed ID: 37652000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.
    Zia FZ; Baumann MH; Belouin SJ; Dworkin RH; Ghauri MH; Hendricks PS; Henningfield JE; Lanier RK; Ross S; Berger A
    Neuropharmacology; 2023 Aug; 233():109528. PubMed ID: 37015315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Psychedelics for Pain: A Scoping Review.
    Goel A; Rai Y; Sivadas S; Diep C; Clarke H; Shanthanna H; Ladha KS
    Anesthesiology; 2023 Oct; 139(4):523-536. PubMed ID: 37698433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
    Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.
    Hutten NRPW; Mason NL; Dolder PC; Kuypers KPC
    Front Psychiatry; 2019; 10():672. PubMed ID: 31572246
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.
    Bender D; Hellerstein DJ
    Psychopharmacology (Berl); 2022 Jun; 239(6):1907-1932. PubMed ID: 35022823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for acute treatment of episodic tension-type headache in adults.
    Derry S; Wiffen PJ; Moore RA
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011888. PubMed ID: 28084009
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.